Targeting the cytochrome bc1 complex for drug development in M. tuberculosis: review

Molecular Diversity - The terminal oxidases of the oxidative phosphorylation pathway play a significant role in the survival and growth of M. tuberculosis, targeting these components lead to...     

Conformational polymorphism in bicalutamide: a quantum chemical study

Bicalutamide is an anti-neoplastic drug widely used for the treatment of prostate cancer and it exhibits conformational polymorphism. Three crystal structures of bicalutamide are reported as racemic mixtures, two of which are polymorphs. In addition, three co-crystals are also reported—two with organic coformers and one with adrenoreceptor (the macromolecular target). All the reported structures show significant conformational differences. Quantum chemical B3LYP/6-31+G(d,p) analysis has been carried out to understand the interplay of intra- and intermolecular interactions leading to the conformational preferences in this molecule. The difference between the two polymorphic forms has been traced to the C5–S8–C11–C12 torsional angle. Inside the cavity of androgen receptor, a completely different conformation is found but it does not correspond to any local minima on the potential energy surface of the drug. A relatively rigid torsional angle C11–C12–C15–N17 is also expected due to a strong five-membered ring intramolecular hydrogen bond (H–O13–C12–C15–O16), which has been reported to be desirable; quantum chemical analysis revealed that this rigidity is of the order of 11 kcal/mol. Ab initio calculations demonstrate that polymorphs and polymorphic co-crystals differ in the extent of intra- and intermolecular hydrogen bonding interactions. The strength of the intermolecular interactions associated with these structures is analyzed in terms of energy release due to dimerization.     

Computational study on the conformational preferences in nateglinide

Ab initio and semi‐empirical calculations were performed on the monomers, dimers and tetramers of the antidiabetic drug nateglinide to understand the conformational preferences and to explore their possible relation with polymorphism. The reported crystal structure of bis(nateglinide) hydronium chloride shows one asymmetric unit consisting of four different conformations of the drug nateglinide. The Becke, three‐parameter, Lee–Yang–Parr /6‐31+G(d,p) optimizations indicate that these conformers are energetically quite comparable and the differences disappear in gas phase. Our analysis shows that Φ (phi) torsion angle of this phenylalanine derivative is responsible for the observed differences in stability among the nateglinide conformations. Four different polymorphs of nateglinide (B, H, S and X2) were reported but the structural differences are not available. This quantum chemical study on the dimers of nateglinide helps in proposing the structures of polymorphs. As per the quantum chemical analysis, the dimer N‐44 is the structure of the stable polymorph, whereas, the dimers N‐AA, N‐CC and N‐AC are almost isoenergetic, thus proposed to be the structures of metastable state. The dimerization and tetramerization energies are estimated to be about ?9.0 and ?38.67 kcal/mol, respectively. The extra stability in tetrameric state compared with the dimeric form is attributed to additional hydrophobic and van der Waals interactions. Copyright © 2011 John Wiley & Sons, Ltd.